Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma, PDAC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06947395
What this trial is testing

Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

Who this might be right for
Cancer of the PancreasPancreatic CancerPancreas Neoplasms+2 more
Immunovia, Inc. 386
Not applicableNot Yet RecruitingNCT07605702
What this trial is testing

The Canopy Cancer Collective Clinical Registry Protocol

Who this might be right for
Gastrointestinal NeoplasmsPancreatic CancerColorectal Cancer+4 more
Canopy Cancer Collective, LLC 100,000
Early research (Phase 1)Study completedNCT04943900
What this trial is testing

BMS-986416 With and Without Nivolumab in Select Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 67
Not applicableNot Yet RecruitingNCT05895214
What this trial is testing

Mesopancreas Study in Pancreatic Cancer

Who this might be right for
PDACPancreatoduodenectomyMargin, Resection+2 more
Heinrich-Heine University, Duesseldorf 500
Not applicableStudy completedNCT02150746
What this trial is testing

Circulating Tumor Cells in Operative Blood

Who this might be right for
Carcinoma, Pancreatic Ductal
University of Florida 3
Testing effectiveness (Phase 2)Looking for participantsNCT07483983
What this trial is testing

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Who this might be right for
Metastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris 60
Not applicableLooking for participantsNCT07587866
What this trial is testing

Panuri Performance Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A 1,100
Testing effectiveness (Phase 2)Looking for participantsNCT07303465
What this trial is testing

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
KRAS G12D MutationsPancreatic Ductal Adenocarcinoma (PDAC)
Ranok Therapeutics (Hangzhou) Co., Ltd. 60
Not applicableTemporarily pausedNCT04700488
What this trial is testing

Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Cedars-Sinai Medical Center 36
Early research (Phase 1)Not Yet RecruitingNCT06913218
What this trial is testing

MRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Who this might be right for
Pancreas CancerPancreas Cancer, Duct Cell Adenocarcinoma
Akeso 60
Early research (Phase 1)Ended earlyNCT02782182
What this trial is testing

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Chicago 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05642962
What this trial is testing

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma+10 more
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Large-scale testing (Phase 3)Active Not RecruitingNCT06625320
What this trial is testing

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 500
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Testing effectiveness (Phase 2)UnknownNCT03634332
What this trial is testing

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreatic Neoplasms
Pancreatic Cancer Research Team 35
Not applicableNot Yet RecruitingNCT06276803
What this trial is testing

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia
Adenocyte, LLC 500
Not applicableWithdrawnNCT04306861
What this trial is testing

Novel MRI Techniques for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06345599
What this trial is testing

PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Second Affiliated Hospital of Soochow University 66
Next Page